Lingen Shi1, Weiming Tang2, Haiyang Hu1, Tao Qiu1, Gifty Marley3, Xiaoyan Liu1, Yuheng Chen1, Yunting Chen1, Gengfeng Fu4. 1. Institute for STI and HIV Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, No. 172 Jiangsu Road, Gulou District, Nanjing, 21009, Jiangsu, China. 2. University of North Carolina Project-China, Guangzhou, 510095, China. 3. Department of Epidemiology and Health Statistics, Nanjing Medical University, Nanjing, China. 4. Institute for STI and HIV Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, No. 172 Jiangsu Road, Gulou District, Nanjing, 21009, Jiangsu, China. fugf@jscdc.cn.
Abstract
BACKGROUND: The COVID-19 pandemic seriously threatens general public health services globally. This study aimed to evaluate the impact of the COVID-19 pandemic on the HIV care continuum in Jiangsu province, China. METHODS: Data on newly diagnosed HIV persons for analysis were retrieved from Chinas' web-based Comprehensive Response Information Management System (CRIMS) for HIV/AIDS from 2016 to 2020. We recorded data for the first 3 months (January to March, 2020) of strictly implementing COVID-19 measures from publicly available disease databases of the Jiangsu provincial Health Committee. We used seasonal autoregressive integrated moving average (SARIMA) and exponential smoothing in forecasting the parameters. Subgroup differences were accessed using Chi-square tests. RESULTS: Compared to the estimated proportions, the HIV testing rates decreased by 49.0% (919,938) in the first three months of implementing COVID-19 measures. Of an estimated 1555 new HIV diagnosis expected in the same period, only 63.0% (980) new diagnoses were recorded. According to actual data recorded during the said period, 980 positively tested persons received confirmatory tests, of which 71.4% (700) were reportedly linked to care. And only 49.5% (235) out of the expected 475 newly diagnosed HIV persons received CD4 cell count testing. Meanwhile 91.6% (208) of newly diagnosed HIV persons who received CD4 count tests reportedly initiated antiretroviral therapy (ART) compared to the 227 expected. Compared to the same period from 2016 to 2019, PLWH less than 30 years old and migrants were more likely to be affected by the COVID-19 policies. CONCLUSIONS: The COVID-19 pandemic negatively impacted HIV healthcare systems in Jiangsu, China. Further measures that can counter the impact of the pandemic are needed to maintain the HIV care continuum.
BACKGROUND: The COVID-19 pandemic seriously threatens general public health services globally. This study aimed to evaluate the impact of the COVID-19 pandemic on the HIV care continuum in Jiangsu province, China. METHODS: Data on newly diagnosed HIV persons for analysis were retrieved from Chinas' web-based Comprehensive Response Information Management System (CRIMS) for HIV/AIDS from 2016 to 2020. We recorded data for the first 3 months (January to March, 2020) of strictly implementing COVID-19 measures from publicly available disease databases of the Jiangsu provincial Health Committee. We used seasonal autoregressive integrated moving average (SARIMA) and exponential smoothing in forecasting the parameters. Subgroup differences were accessed using Chi-square tests. RESULTS: Compared to the estimated proportions, the HIV testing rates decreased by 49.0% (919,938) in the first three months of implementing COVID-19 measures. Of an estimated 1555 new HIV diagnosis expected in the same period, only 63.0% (980) new diagnoses were recorded. According to actual data recorded during the said period, 980 positively tested persons received confirmatory tests, of which 71.4% (700) were reportedly linked to care. And only 49.5% (235) out of the expected 475 newly diagnosed HIV persons received CD4 cell count testing. Meanwhile 91.6% (208) of newly diagnosed HIV persons who received CD4 count tests reportedly initiated antiretroviral therapy (ART) compared to the 227 expected. Compared to the same period from 2016 to 2019, PLWH less than 30 years old and migrants were more likely to be affected by the COVID-19 policies. CONCLUSIONS: The COVID-19 pandemic negatively impacted HIV healthcare systems in Jiangsu, China. Further measures that can counter the impact of the pandemic are needed to maintain the HIV care continuum.
Authors: Sushena Reza-Paul; Lisa Lazarus; Partha Haldar; Manisha Reza Paul; Bhagya Lakshmi; Manjula Ramaiah; Akram Pasha; Syed Hafeez Ur Rahman; K T Venukumar; M S Venugopa; Bharat Bhushan Rewari; Robert Lorway Journal: WHO South East Asia J Public Health Date: 2020-09
Authors: Kaja Abbas; Simon R Procter; Kevin van Zandvoort; Andrew Clark; Sebastian Funk; Tewodaj Mengistu; Dan Hogan; Emily Dansereau; Mark Jit; Stefan Flasche Journal: Lancet Glob Health Date: 2020-07-17 Impact factor: 26.763
Authors: Sharon R Lewin; Timothy Attoye; Cathy Bansbach; Brian Doehle; Karine Dubé; Mark Dybul; Devi SenGupta; Adam Jiang; Rowena Johnston; Rosanne Lamplough; Joseph M McCune; Gary J Nabel; Thumbi Ndung'u; John Pottage; David Ripin; James F Rooney; Izukanji Sikazwe; Moses Nsubuga; Mitchell Warren; Steven G Deeks Journal: Lancet HIV Date: 2020-11-27 Impact factor: 12.767
Authors: Ross D Booton; Gengfeng Fu; Louis MacGregor; Jianjun Li; Jason J Ong; Joseph D Tucker; Katy M E Turner; Weiming Tang; Peter Vickerman; Kate M Mitchell Journal: medRxiv Date: 2020-10-13
Authors: Cheryl Keech; Gary Albert; Iksung Cho; Andreana Robertson; Patricia Reed; Susan Neal; Joyce S Plested; Mingzhu Zhu; Shane Cloney-Clark; Haixia Zhou; Gale Smith; Nita Patel; Matthew B Frieman; Robert E Haupt; James Logue; Marisa McGrath; Stuart Weston; Pedro A Piedra; Chinar Desai; Kathleen Callahan; Maggie Lewis; Patricia Price-Abbott; Neil Formica; Vivek Shinde; Louis Fries; Jason D Lickliter; Paul Griffin; Bethanie Wilkinson; Gregory M Glenn Journal: N Engl J Med Date: 2020-09-02 Impact factor: 91.245